Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients

  • André Tichelli
    Hematology, University Hospital, Basel, Switzerland
  • Eric Beohou
    EBMT Paris Study Office/CEREST-TC, Hôpital Saint Antoine, Paris, France
  • Myriam Labopin
    EBMT Paris Study Office/CEREST-TC, Hôpital Saint Antoine, Paris, France
  • Gérard Socié
    Department of Hematology–BMT, Hôpital St Louis, Paris, France
  • Alicia Rovó
    Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
  • Manuela Badoglio
    EBMT Paris Study Office/CEREST-TC, Hôpital Saint Antoine, Paris, France
  • Anja van Biezen
    EBMT Data Office Leiden, Leiden University Medical Center, Leiden, the Netherlands
  • Peter Bader
    Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, Frankfurt, Germany
  • Rafael F. Duarte
    Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain
  • Grzegorz Basak
    Department of Hematology, Oncology and Internal Medicine, Central Clinical Hospital, the Medical University of Warsaw, Warsaw, Poland
  • Nina Salooja
    Center for Haematology, Imperial College, London, United Kingdom

収録刊行物

  • JAMA Oncology

    JAMA Oncology 5 (2), 229-, 2019-02-01

    American Medical Association (AMA)

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ